Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death
Journal of Clinical Investigation · 16.01.2024 · 134 (2)
DOI: 10.1172/jci170882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.01.2024. Verfasst von Denisa Weis und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Kepler University Hospital, School of Medicine, Johannes Kepler University, Linz, Austria. Hauptthemen laut MEDLINE: Proteins, Agammaglobulinemia. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Suppressor of lin-12-like-HMG-CoA reductase degradation 1 (SEL1L-HRD1) ER-associated degradation (ERAD) plays a critical role in many physiological processes in mice, including immunity, water homeostasis, and energy metabolism; however, its relevance and importance in humans remain unclear, as no disease variant has been identified. Here, we report a biallelic SEL1L variant (p. Cys141Tyr) in 5 patients from a consanguineous Slovakian family. These patients presented with not only ERAD-associated neurodevelopmental disorders with onset in infancy (ENDI) syndromes, but infantile-onset agammaglobulinemia with no mature B cells, resulting in frequent infections and early death. This variant disrupted the formation of a disulfide bond in the luminal fibronectin II domain of SEL1L, largely abolishing the function of the SEL1L-HRD1 ERAD complex in part via proteasomal-mediated self destruction by HRD1. This study reports a disease entity termed ENDI-agammaglobulinemia (ENDI-A) syndrome and establishes an inverse correlation between SEL1L-HRD1 ERAD functionality and disease severity in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Kepler University Hospital, School of Medicine, Johannes Kepler University, Linz, Austria.
- Department of Pediatrics, Faculty of Medicine, Comenius University Bratislava and National Institute of Children's Diseases, Bratislava, Slovakia.
- Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
- Department of Molecular & Integrative Physiology and.
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Pediatric Neurology, Faculty of Medicine, Comenius University Bratislava and National Institute of Children's Diseases, Bratislava, Slovakia.
Förderung
- NIDDK NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- Austrian Science Fund FWF
- National Institutes of Health
- Austrian Science Fund
- National Ataxia Foundation
Zitieren
APA
Weis, D., Lin, L. L., Wang, H. H., Li, Z. J., Kusikova, K., Ciznar, P., Wolf, H. M., Leiss-Piller, A., Wang, Z., Wei, X., Weis, S., Skalicka, K., Hrckova, G., Danisovic, L., Soltysova, A., Yang, T. T., Feichtinger, R. G., Mayr, J. A., & Qi, L. (2024). Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death. Journal of Clinical Investigation, 134(2). https://doi.org/10.1172/jci170882
Vancouver
Weis D, Lin LL, Wang HH, Li ZJ, Kusikova K, Ciznar P, et al. Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death. Journal of Clinical Investigation. 2024;134(2). doi:10.1172/jci170882
BibTeX
@article{Weis2024,
author = {Weis, Denisa and Lin, Liangguang L and Wang, Huilun H and Li, Zexin Jason and Kusikova, Katarina and Ciznar, Peter and Wolf, Hermann M and Leiss-Piller, Alexander and Wang, Zhihong and Wei, Xiaoqiong and Weis, Serge and Skalicka, Katarina and Hrckova, Gabriela and Danisovic, Lubos and Soltysova, Andrea and Yang, Tingxuan T and Feichtinger, René Günther and Mayr, Johannes A and Qi, Ling},
title = {Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {2},
doi = {10.1172/jci170882}
}
EUVIMED